X. Tang and M. J. Pikal. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm. Res.
L. A. Trissel. Handbook of Injectable Drugs. ASHP, Bethesda, Maryland, 1994.
T. W. Randolph. Phase separation of excipients during lyophilization: effects on protein stability. J. Pharm. Sci.
M. J. Pikal. Freeze Drying. Encyclopedia of Pharmaceutical Technology, Marcel Dekker, Inc. p.1299–1326, (2002).
E. Y. Shalaev, F. Franks, and P. Echlin. Crystalline and amorphous phases in the ternary system water-sucrose-sodium chloride. J. Phys. Chem.
E. Y. Shalaev. The impact of buffer on processing and stability of freeze-dried dosage forms, part 1: solution freezing behavior. American Pharm. Rev.
R. G. Bates. Determination of pH. Theory and Practice, 2nd ed. Wiley, New York, 1973, p.90.
K. A. Pikal-Cleland, J. L. Cleland, T. J. Anchordoquy, and J. F. Carpenter. Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems. J. Pharm. Sci.
M. J. Pikal, K. M. Dellerman, M. L. Roy, and R. M. Riggin. The effect of formulation variables on the stability of freeze-dried human growth harmone. Pharm. Res.
S. S. Larsen. Studies on stability of drugs in frozen systems. IV. The stability of benzylpenicillin sodium in frozen aqueous solutions. Dansk Tidsskr. Farm.
M. P. W. M. te Booy, R. A. de Ruiter, and A. L. J. de Meere. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry. Pharm. Res.
M. J. Akers, N. Milton, S. R. Byrn, and S. L. Nail. Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength. Pharm. Res.
A. Pyne and R. Suryanarayanan. Phase transitions of glycine in frozen aqueous solutions and freeze-drying. Pharm. Res.
S. S. Larsen. Studies on stability of drugs in frozen systems. VI. The effect of freezing on pH for buffered aqueous solutions. Arch. Pharm. Chemi Sci. Ed.
L. van den Berg. pH changes in buffers and foods during freezing and subsequent storage. Cryobiology
L. van den Berg and D. Rose. Effect of freezing on the pH and composition of sodium and potassium phosphate solutions: the reciprocal system: KH2
O. Arch. Biochim. Biophys.
L. van den Berg and D. Rose. The effect of addition of sodium and potassium chloride to the reciprocal system: KH2
O on pH and composition during freezing. Arch. Biochim. Biophys.
G. Gomez, M. J. Pikal, and N. Rodriguez-Hornedo. Effect of initial buffer composition on pH changes during far-from equilibrium freezing of sodium phosphate buffer solutions. Pharm. Res.
G. Gomez. Crystallization-related pH changes during freezing of sodium phosphate buffer solutions, Ph.D. Dissertation, University of Michigan, Ann Arbor, Michigan, 1995.
Y. Orii and M. Morita. Measurement of the pH of frozen buffer solutions by using pH indicators. J. Biochem.
B. S. Chang and C. S. Randall. Use of subambient thermal analysis to optimize protein lyophilization. Cryobiology
N. Murase and F. Franks. Salt precipitation during the freeze-concentration of phosphate buffer solutions. Biophys. Chem.
N. Murase, P. Echlin, and F. Franks. The structural states freeze-concentrated and freeze-dried phosphates studied by scanning electron-microscopy and differential scanning calorimetry. Cryobiology
R. K. Cavatur and R. Suryanarayanan. Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry. Pharm. Res.
A. Pyne, K. Chatterjee, and R. Suryanarayanan. Crystalline to amorphous transition of disodium hydrogen phosphate during primary drying. Pharm. Res.
N. Blagden, R. Davey, M. Song, M. Quayle, S. Clark, D. Taylor, and A. Nield. A novel batch cooling crystallization for in situ
monitoring of solution crystallization using energy dispersive X-ray diffraction. Cryst. Growth Design
R. Surana and R. Suryanarayanan. Quantitation of crystallinity in substantially amorphous pharmaceuticals and study of crystallization kinetics by X-ray powder diffractometry. Powder Diffr.
C. Nunes, R. Suryanarayanan, C. E. Botez, and P .W. Stephens. Characterization and crystal structure of d
-mannitol hemihydrate. J. Pharm. Sci.
C. Nunes. Use of High-Intensity X-Radiation in Solid-State Characterization of Pharmaceuticals, Ph.D. Dissertation, Department of Pharmaceutics, University of Minnesota, 2005.
C. Nunes, A. Mahendrasingam, and R. Suryanarayanan. Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry. Pharm. Res.
C. Mohan. Buffers: a guide for the preparation and use of buffers in biological systems. Calbiochem®, EMD Biosciences, Inc. 2003.
A. P. Hammersley. ESRF internal report, ESRF97HA02T, “Fit2D: an introduction and overview,” (1997).
A. P. Hammersley, S. O. Svensson, M. Hanfland, A. N. Fitch, and D. Häusermann. Two-dimensional detector software: from real detector to idealized image or two-theta scan. High Press. Res.
Powder Diffraction File. (hexagonal ice: PDF-2, Card #00-042-1142), International Centre for Diffraction Data, Newtown Square, PA, 1996.
Powder Diffraction File. (disodium hydrogen phosphate dodecahydrate: PDF-2, Card #00-011-0657), International Centre for Diffraction Data, Newtown Square, PA, 1996.
D. H. Templeton, H. W. Ruben, and A. Zalkin. Entropy and crystal structure of hydrates of disodium hydrogen phosphate. J. Phys. Chem.
A. Ghule, C. Bhongale, and H. Chang. Monitoring dehydration and condensation processes of Na2
O using thermo-Raman spectroscopy. Spectrochim. Acta
, Part A: Mol. Biomol. Spectrosc.
(7), 1529–1539, (2003).CrossRef
Powder Diffraction File. (crystalline phases of disodium hydrogen phosphate and monosodium dihydrogen phosphate, Na2HPO4•7H2O: PDF-2, Card #00-010-0191; NaH2PO4•2H2O: PDF-2, Card #00-010-0198; NaH2PO4•H2O: PDF-2, Card #00-011-0651; NaH2PO4: PDF-2, Card #00-011-0659), International Centre for Diffraction Data, Newtown Square, PA, 1996.